Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

s."

Operational Key Events:

  • Raised $31.0 million from a registered direct offering that yielded $29.0 million in cash, net of $2.0 million of offering costs

  • Elected Ginger D. Constantine, M.D. to the Company's Board of Directors

  • FDA appointed Arthritis Advisory Committee recommended marketing approval for KRYSTEXXA

  • Presented six abstracts (two oral presentations and four posters) about KRYSTEXXA at the European League Against Rheumatism (EULAR) 2009 Annual Congress addressing various aspects of treatment failure gout.

  • Received a complete response letter from the FDA on July 31, 2009 stating that the FDA cannot at this time approve the BLA for KRYSTEXXA as a treatment for chronic gout in patients refractory to conventional therapy. The complete response letter cited deficiencies with the CMC section of the BLA and also provided the current draft of the proposed labeling and further guidance regarding a Risk Evaluation and Mitigation Strategy (REMS). We expect to resubmit our BLA to the FDA in early 2010 to respond to the FDA's complete response letter.

  • Received notification from the FDA of a tentative meeting date scheduled for mid-September 2009 to discuss the complete response letter issued by the FDA in response to the "Type A" Meeting request filed by the Company.

Financial Results of Operations for the Three Months Ended June 30, 2009

Total revenues for the second quarter of 2009 were $0.7 million compared with $0.4 million for the second quarter of 2008, an increase of $0.3 million. The increase is primarily the result of higher product sales of oxandrolone, our authorized generic product that promotes weight gain f
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... AZ (PRWEB) June 20, 2013 Pedata ... recreational vehicle sales, warns campers that improperly handled food can ... , Now that summertime has arrived, many RV campers are ... fresco. Whether they are eating outdoors at the campground or ... are ever present and should be avoided at all costs. ...
(Date:6/20/2013)... 2013 TASC, a national leader ... new service to deal with funding the Patient-Centered ... Protection & Affordable Care Act (PPACA), the PCORI ... clinical effectiveness, and appropriateness" of different medical treatments. ... its own, with funding in part by employer-paid ...
(Date:6/20/2013)... June 20, 2013 Startups who need ... their sales or test new markets, and international companies ... have a new sales outsourcing company to ... revenue. , Strategy Sales Partners is a ... by business owners for business owners, Strategy Sales Partners ...
(Date:6/19/2013)... Everyone is looking for ways to improve general health. Sublime Beauty® ... is called Skin Brushing . Skin Brushing can be incorporated ... to improve health and skin quality. It is fun to ... Brushing improves general health because:, , it boosts ... drain toxins , it clears skins of dead cells ...
(Date:6/19/2013)... 2013 Go Classy Tours has the reputation ... for over 25 Years. These resorts, draw many clients ... nude bars and nude hot tubs. Grand Lido Negril ... When SuperClubs re-branded the resort to a Breezes and dis-continued ... of the Resort fell off dramatically. "Groups just went ...
Breaking Medicine News(10 mins):Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 3Health News:TASC Service Helps Employers Handle New Burdens for Health Reimbursement Arrangement Plans 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2
... MD The American Institute of Ultrasound in ... Point-of-Care Use of Ultrasound on November 8 ... a cross section of the ultrasound community, drawing ... to explore professional issues related to emerging point-of-care ...
... The presence of one to four circulating tumor cells ... doubled patient,s risk of cancer relapse and death, and five ... by 300 percent, according to Phase III results of the ... but before chemotherapy treatment. Results of this study were ...
... cancer patients who had circulating tumor cells (CTCs) in ... by autologous stem cell transplantation had poor outcomes, according ... Cancer Center. Patients with CTCs in their ... with these cells in their blood after the stem ...
... resistance, a triple-drug cocktail for triple negative breast cancer, ... study highlights scheduled to be presented by Johns Hopkins ... San Antonio Breast Cancer Symposium, held Dec. 8-12. ... at the symposium. SIMPLE FINGERTIP TEST MAY IDENTIFY ...
... -- Toddlers who play with different-shaped objects learn new words ... have similar shapes, a new study finds. University of ... old and knew about 17 object names at the start ... objects by playing with toys that were nearly identical, while ...
... By Maureen Salamon HealthDay Reporter , FRIDAY, ... considered nature,s ideal nourishment for babies. But some ... subject of fresh scrutiny by the U.S. Food and Drug ... share their milk with needy infants at all. ...
Cached Medicine News:Health News:AIUM spearheads collaboration to develop guidelines for point-of-care ultrasound applications 2Health News:Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer 2Health News:CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer 2Health News:Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome 2Health News:FDA Weighs In as Sharing of Breast Milk Booms 2Health News:FDA Weighs In as Sharing of Breast Milk Booms 3
(Date:6/19/2013)... June 19, 2013 Dr. Davis Lee ... of four recipients of the 2013 AMDIS Award, a ... medical informatics. "On behalf of Allscripts, ... in leadership, innovation and continuous efforts to improve patient ... , President and Chief Executive Officer of Allscripts. "We ...
(Date:6/19/2013)... INDIANAPOLIS , June 19, 2013 Eli ... issued an alert about two illegal scams, purportedly using ... Animal Health, that are actively targeting the public through ... and Elanco have no connection to any foreign lottery ... recruiting described by the job-seeking victims of the scam. ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in ... lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe ... even in patients who were at high-risk due to ...
Breaking Medicine Technology:Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6
... 27, 2011 Express Scripts, Inc. (Nasdaq: ESRX ... conferences in November: Credit Suisse 2011 Healthcare Conference ... a.m. eastern). Lazard Capital Markets, 8th Annual Healthcare ... These presentations will also be broadcast via ...
... WARWICK, R.I., Oct. 27, 2011 ... the power of connected healthcare in partnership with ... Virtual Lifetime Electronic Records (VLER) initiative for veterans ... electronic medical records for veterans and military personnel ...
Cached Medicine Technology:MEDfx Demonstrates Potential of Connected Healthcare by Enabling Military and Civilian Medical Professionals to Securely Access Records, Improve Care Coordination 2
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
... . The digital 200 V/2000 mA PSE ... in 1 volt and 10 mA increments. • ... SEA 2000® apparatus simultaneously at 55°C. Features: ... of voltage, current and time • Voltage, mA ...
... The PowerPac HV high-voltage power ... supports an increased output of ... 400 W. Built-in infrared capability ... Power cord and instructions are ...
... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free-flowing ... to 0.05 Gel Point (3%): less than or equal ... to 75C Gel Strength (3%): greater than or equal ... equal to 10% Sulfate: less than or equal to ...
Medicine Products: